VYMADA 200 MG 7 TABLETS | Sacubitril + Valsartan for Heart Failure
VYMADA 200 MG 7 TABLETS contain Sacubitril 97 mg and Valsartan 103 mg, a prescription ARNI medicine used to treat chronic heart failure and reduce the risk of hospitalization and cardiovascular death.
VYMADA 200 MG 7 TABLETS
VYMADA 200 MG 7 TABLETS (Sacubitril 97 mg + Valsartan 103 mg): Comprehensive Guide and Benefits
Introduction to VYMADA 200 MG 7 TABLETS
ARNI Therapy for Chronic Heart Failure
VYMADA 200 MG 7 TABLETS are a prescription-only medicine containing Sacubitril 97 mg and Valsartan 103 mg. This combination belongs to the class of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) and is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). It helps improve heart function, reduce the risk of hospitalization due to heart failure, and lower the risk of cardiovascular death when used as part of a comprehensive treatment plan.
Key Benefits of VYMADA 200 MG 7 TABLETS
Helps improve heart pumping efficiency.
Reduces the risk of hospitalization due to chronic heart failure.
Lowers the risk of cardiovascular death.
Helps relieve symptoms such as breathlessness and fatigue.
Supports improved quality of life when used alongside standard heart failure therapy.
How VYMADA 200 MG Works
VYMADA combines two medicines with complementary actions:
Sacubitril inhibits the enzyme neprilysin, increasing beneficial natriuretic peptides that promote blood vessel relaxation, sodium excretion, and reduced strain on the heart.
Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and reduces the workload on the heart.
Together, these actions improve heart function and reduce the progression of chronic heart failure.
Usage Instructions
Take the medicine exactly as prescribed by your healthcare provider.
May be taken with or without food.
Swallow the tablet whole with water.
Take it at the same time each day.
Continue treatment regularly even if you feel well.
Do not stop taking the medicine without consulting your doctor.
Medicinal Advantages
Proven therapy for chronic heart failure with reduced ejection fraction.
Helps decrease hospitalization related to heart failure.
Improves long-term cardiovascular outcomes.
Combines two complementary mechanisms in one tablet.
Convenient oral treatment as part of guideline-directed heart failure management.
NOTE: VYMADA should not be taken together with an ACE inhibitor. A washout period of at least 36 hours is required when switching from an ACE inhibitor to VYMADA.
Off-Label Uses
VYMADA should generally be used only for its approved indications unless a healthcare specialist recommends otherwise.
Expert Advice
Monitor your blood pressure regularly.
Attend scheduled kidney function and potassium blood tests.
Follow a low-sodium diet if advised.
Limit alcohol consumption.
Report swelling of the face, lips, tongue, or difficulty breathing immediately, as these may indicate angioedema.
Precautions
Pregnancy & Breastfeeding
Do not use VYMADA during pregnancy, as it may cause serious harm to the unborn baby. Breastfeeding is generally not recommended during treatment.
Kidney & Liver Function
Use with caution in patients with kidney or liver impairment. Regular monitoring of kidney function and blood potassium levels is recommended. Dose adjustments may be necessary in certain patients.
Drug Interactions
Inform your healthcare provider if you are taking:
ACE inhibitors.
Other ARBs.
Potassium supplements or potassium-sparing diuretics.
NSAIDs (such as ibuprofen or diclofenac).
Lithium.
Aliskiren.
These medicines may increase the risk of serious interactions.
Existing Medical Conditions
Tell your healthcare provider if you have:
Chronic heart failure.
Kidney disease.
Liver disease.
Low blood pressure.
History of angioedema.
Diabetes.
Storage Instructions
Store below 30°C.
Keep in the original blister pack.
Protect from moisture and excessive heat.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is VYMADA 200 MG used for?
A: It is used to treat chronic heart failure, helping reduce the risk of hospitalization and cardiovascular death while improving heart function.
Q: What are the active ingredients?
A: Each tablet contains Sacubitril 97 mg and Valsartan 103 mg.
Q: What are the common side effects?
A: Common side effects include low blood pressure, dizziness, cough, increased potassium levels, and impaired kidney function.
Q: Can I take VYMADA with an ACE inhibitor?
A: No. VYMADA should not be taken together with an ACE inhibitor. A minimum 36-hour washout period is required when switching therapies.
Q: Can I stop taking VYMADA if I feel better?
A: No. Continue taking the medicine as prescribed. Stopping treatment without medical advice may worsen heart failure.
Q: Is VYMADA available without a prescription?
A: No. VYMADA 200 MG is a prescription-only medicine and should be used under the supervision of a qualified healthcare professional.
Product Tags
VYMADA 200 MG 7 TABLETS, Sacubitril 97 mg, Valsartan 103 mg, Sacubitril Valsartan Tablet, ARNI Medicine, Heart Failure Treatment, Chronic Heart Failure, HFrEF Medicine, Cardiovascular Medicine, Prescription Heart Medicine, Heart Failure Therapy, Blood Pressure Medicine, Cardiac Care, Angiotensin Receptor Neprilysin Inhibitor, Heart Function Support, Once Daily Tablet, Novartis VYMADA, Sacubitril Valsartan 200 mg, Heart Failure Medication, Prescription Cardiovascular Tablet
